U.S. Sens. Katie Britt (R-Montgomery) and Tommy Tuberville (R-Auburn) joined other Senate Republicans in calling on U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. and U.S. Food and Drug Administration (FDA) Commissioner Dr. Martin Makary to reconsider the recent approval of a new generic abortion pill by the FDA.

The Senators urged HHS and FDA to review the decision to approve a generic version of mifepristone — currently the leading drug used to perform chemical abortions. Not only is this drug deadly for preborn babies and a serious health risk for expectant mothers, but the decision also runs afoul of states with pro-life laws on the books.

“We commend your recent statements acknowledging the data discrepancies surrounding abortion pill safety a

See Full Page